AAAAAA
Results:
1-8
|
Results: 8
Authors:
Pfreundschuh, M
Hasenclever, D
Loeffler, M
Ehninger, G
Schmitz, N
Kirchner, H
Koch, P
Lathan, B
Rueffer, U
Sextro, M
Franklin, J
Tesch, H
Diehl, V
Citation: M. Pfreundschuh et al., Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF, ANN ONCOL, 12(4), 2001, pp. 471-477
Authors:
Bohlen, H
Kessler, M
Sextro, M
Diehl, V
Tesch, H
Citation: H. Bohlen et al., Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels - Clinical significance of interleukin-l0 serum levels for Hodgkin's disease, ANN HEMATOL, 79(3), 2000, pp. 110-113
Authors:
Lieberz, D
Sextro, M
Paulus, U
Franklin, J
Tesch, H
Diehl, V
Citation: D. Lieberz et al., How to restrict liver biopsy to high-risk patients in early-stage Hodgkin's disease, ANN HEMATOL, 79(2), 2000, pp. 73-78
Authors:
Anagnostopoulos, I
Hansmann, ML
Franssila, K
Harris, M
Harris, NL
Jaffe, ES
Han, J
van Krieken, JM
Poppema, S
Marafioti, T
Franklin, J
Sextro, M
Diehl, V
Stein, H
Citation: I. Anagnostopoulos et al., European Task Force on Lymphoma project on lymphocyte predominance Hodgkindisease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes, BLOOD, 96(5), 2000, pp. 1889-1899
Authors:
Diehl, V
Sextro, M
Franklin, J
Hansmann, ML
Harris, N
Jaffe, E
Poppema, S
Harris, M
Franssila, K
van Krieken, J
Marafioti, T
Anagnostopoulos, I
Stein, H
Citation: V. Diehl et al., Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's disease, J CL ONCOL, 17(3), 1999, pp. 776-783
Authors:
Diehl, V
Franklin, J
Sextro, M
Mauch, PM
Citation: V. Diehl et al., Clinical presentation and treatment of lymphocyte predominance Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 563-582
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Ruffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duhmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP: A new regimen for advanced Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 67-71
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Rueffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duehmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group, J CL ONCOL, 16(12), 1998, pp. 3810-3821
Risultati:
1-8
|